Venezuelan equine encephalitis
Role of adhesion molecules and inflammation in Venezuelan equine encephalitis virus infected mouse brain
9
Testosterone correlates with Venezuelan equine encephalitis virus infection in macaques
5
Potential Sources of the 1995 Venezuelan Equine Encephalitis Subtype IC Epidemic
10
Glycosaminoglycan Binding Properties of Natural Venezuelan Equine Encephalitis Virus Isolates
7
Pseudoinfectious Venezuelan Equine Encephalitis Virus: a New Means of Alphavirus Attenuation
13
Role of Dendritic Cell Targeting in Venezuelan Equine Encephalitis Virus Pathogenesis
9
Venezuelan equine encephalitis virus nonstructural protein 2 in the host cell
241
Protein Phosphatase 1α Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation
18
Noncytopathic Replication of Venezuelan Equine Encephalitis Virus and Eastern Equine Encephalitis Virus Replicons in Mammalian Cells
12
Blood genomic profiles of exposures to Venezuelan equine encephalitis in Cynomolgus macaques (Macaca fascicularis)
11
Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
6
Envelope Glycoprotein Mutations Mediate Equine Amplification and Virulence of Epizootic Venezuelan Equine Encephalitis Virus
6
Replicon Particles of Venezuelan Equine Encephalitis Virus as a Reductionist Murine Model for Encephalitis
12
Ablation of Programmed −1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity
13
Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains
9
A putative receptor for Venezuelan equine encephalitis virus from mosquito cells.
8
Laboratory studies of Venezuelan equine encephalitis virus in equines, Texas, 1971
8
Temperature-sensitive Steps in the Biosynthesis of Venezuelan Equine Encephalitis Virus
7
jit609.pdf
12
Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins
8